Fool.com
The World's Greatest Investing Community
Results 1 - 10 of 508 : 1 2 3 4 5 6 7 8 9 Next
Tired of Waiting, Teva Advances
When all else fails, just follow the established pathway to approval.
Fool Blog: Investment Classics for Short Attention Spans
Don't have time to read the greats? Don't worry. Here's all you need to know.
Abbott Makes All the Right Moves
You've got to know when to hold 'em and know when to fold 'em.
Merck Makes a Mark on Good Cholesterol
Can't profit from fighting bad lipoproteins? Start boosting the good ones.
5-Star Stocks Poised to Pop: Abbott Labs
Market-trouncing returns could be written in these five stars.
Your Ticket to True Investing Wealth
In a word: Compounding.
The Key Ingredient for Your Financial Success
Without this, you wouldn't be the investor you are.
A Mostly Meaningless FDA Approval
After an accelerated approval, the positive effects of a full approval are minimal.
A Big Upgrade for Amylin Pharmaceuticals
This bullish call comes from more than just one analyst.
Novartis Didn't Know JAK, Until Now
A drug deal Jellyvision could be proud of.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK